文献速递肿瘤 PET/CT

整合[18F]FDG PET/CT影像组学的小唾液腺癌预后模型的开发与验证

Development and validation of a prognostic model incorporating [18F]FDG PET/CT radiomics for patients with minor salivary gland carcinoma.
PubMed 文献 · EJNMMI Res · 2020-07-06

该研究回顾性纳入75例接受根治性治疗的小唾液腺癌患者,按1.5:1随机分为训练组45例和验证组30例,提取PET影像组学特征并结合临床参数构建预后模型。模型对总生存的C指数为0.83,优于AJCC分期和高危组织学;对总生存和复发无生存的C指数分别为0.88和0.87,优于列线图。

要点

  • 训练组中SUVmax与离散强度熵均高、体能状态差或N2c-N3期与总生存差独立相关。
  • 新模型对总生存的C指数0.83,优于AJCC分期的0.65和高危组织学的0.54。
  • 新模型对总生存和复发无生存的C指数分别为0.88和0.87,均优于列线图。

核心结论

  • 作者开发了一种整合[18F]FDG PET/CT影像组学的新型预后模型,可能有助于改进小唾液腺癌患者的结局预测。

研究设计与样本

  • 回顾性分析75例接受根治性治疗的小唾液腺癌患者的治疗前[18F]FDG PET/CT图像,按1.5:1随机分为训练组45例和验证组30例。
  • 主要结局指标为总生存和复发无生存,全部患者随访至少30个月或至死亡。
  • 在PET图像上分割肿瘤和淋巴结后提取影像组学特征,用ROC曲线分析评估PET影像组学和临床参数的预后意义,将对总生存和复发无生存有显著影响的变量纳入多因素Cox回归模型,随后用递归分割分析构建预后指数并在验证组检验其性能。

主要发现

  • 整个队列中位随访时间为59.5个月,训练组发生18例复发、19例死亡,验证组发生13例复发、8例死亡。
  • 训练组中与总生存差独立相关的两个因素为:SUVmax和离散强度熵均高的肿瘤,以及体能状态差或N2c-N3期。
  • 基于上述因素构建的预后模型对总生存的C指数为0.83,高于AJCC分期的0.65(P=0.005)和高危组织学的0.54(P<0.001)。
  • 该指数对总生存的C指数为0.88,优于列线图的0.70(P=0.017);对复发无生存的C指数为0.87,优于列线图的0.72(P=0.004)。

关键数值与推荐

  • 训练组中SUVmax和离散强度熵均高的肿瘤与总生存差独立相关。
  • 训练组中体能状态差或N2c-N3期与总生存差独立相关。
  • 预后模型对总生存的C指数为0.83,AJCC分期为0.65(P=0.005),高危组织学为0.54(P<0.001)。
  • 预后指数对总生存的C指数为0.88,列线图为0.70(P=0.017);对复发无生存的C指数为0.87,列线图为0.72(P=0.004)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to develop and validate a prognostic model incorporating [18F]FDG PET/CT radiomics for patients of minor salivary gland carcinoma (MSGC). METHODS: We retrospectively reviewed the pretreatment [18F]FDG PET/CT images of 75 MSGC patients treated with curative intent. Using a 1.5:1 ratio, the patients were randomly divided into a training and validation group. The main outcome measurements were overall survival (OS) and relapse-free survival (RFS). All of the patients were followed up for at least 30 months or until death. Following segmentation of tumors and lymph nodes on PET images, radiomic features were extracted. The prognostic significance of PET radiomics and clinical parameters in the training group was examined using receiver operating characteristic curve analysis. Variables showing a significant impact on OS and RFS were entered into multivariable Cox regression models. Recursive partitioning analysis was subsequently implemented to devise a prognostic index, whose performance was examined in the validation group. Finally, the performance of the index was compared with clinical variables in the entire cohort and nomograms for surgically treated cases. RESULTS: The training and validation groups consisted of 45 and 30 patients, respectively. The median follow-up time in the entire cohort was 59.5 months. Eighteen relapse, 19 dead, and thirteen relapse, eight dead events were found in the training and validation cohorts, respectively. In the training group, two factors were identified as independently associated with poor OS, i.e., (1) tumors with both high maximum standardized uptake value (SUVmax) and discretized intensity entropy and (2) poor performance status or N2c-N3 stage. A prognostic model based on the above factors was devised and showed significant higher concordance index (C-index) for OS than those of AJCC stage and high-risk histology (C-index: 0.83 vs. 0.65, P = 0.005; 0.83 vs. 0.54, P < 0.001, respectively). This index also demonstrated superior performance than nomogram for OS (C-index: 0.88 vs. 0.70, P = 0.017) and that for RFS (C-index: 0.87 vs. 0.72, P = 0.004). CONCLUSIONS: We devised a novel prognostic model that incorporates [18F]FDG PET/CT radiomics and may help refine outcome prediction in patients with MSGC.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Cheng NM, Hsieh CE, Fang YD, et al. Development and validation of a prognostic model incorporating [18F]FDG PET/CT radiomics for patients with minor salivary gland carcinoma. EJNMMI Res. 2020. PMID: 32632638. doi:10.1186/s13550-020-00631-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。